Previous 10 | Next 10 |
Summary The FDA is working with congress to extend its regulatory arm over the gene testing market. Veracyte's products are marketed as LDTs and are not approved by the FDA. Regulatory risk weighs against Veracyte's relatively low cash burn and robust balance sheet, underpinni...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list ...
Summary Pharmaceuticals and biotechnology have the best value and quality scores. Healthcare providers look undervalued relative to 11-year averages. Other healthcare industries don’t look attractive. Focus on a biotech ETF: GNOM (and why I don’t like it). ...
In this podcast, Motley Fool senior analyst Jim Gillies discusses topics including: As horror movie fans get excited for the release of Halloween Ends , Motley Fool producer Ricky Mulvey talks with Catie Peiper, a member of The Motley Fool team, about the economics of horror movies....
Summary The management team at General Electric filed some valuable information regarding the upcoming spinoff of its healthcare operations. This new entity, GE HealthCare, is worth a significant amount of money, likely more than General Electric as a whole right now. This pre...
Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, qual...
The manufacturing site joins an exclusive list of facilities recognized for leveraging digital technology to increase performance while improving sustainability Agilent Technologies Inc. (NYSE: A) today announced the World Economic Forum’s Global Lighthouse Ne...
In this Motley Fool Money podcast, Motley Fool senior analyst Maria Gallagher discusses: Also, you may enjoy a cold Sam Adams beer, Angry Orchard cider, or Truly hard seltzer, but does that make the owner of those brands -- The Boston Beer Company -- a good investment? Motley Fo...
Increased testing capacity will provide greater understanding of microplastics contamination in the environment Agilent Technologies Inc. (NYSE: A) today announced the release of its enhanced 8700 LDIR Chemical Imaging System , which has been further optimized for th...
Agilent will fund STEM students from underrepresented groups, and provide lab instrumentation and mentorship to support postgraduate research in the life sciences Agilent Technologies Inc. (NYSE: A) is launching a partnership with Delaware State University (DSU), a leading h...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...
Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2024 after the stock market closes on Aug. 21. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT. To join the listen-only conference call webcast,...